7751 - 7775 of 8620 Results
Title
Year
-
OPENTitle: PP1 Phosphatase Complexes: Undruggable No LongerJournal Name: CellPublisher: Elsevier BVVol: 174Issue #: 5Start Page: 1049End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007Best OA location URL: http://www.cell.com/article/S0092867418310237/pdfCitation Count: 10
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 17
- BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease2022OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://doi.org/10.3389/fneur.2022.1053591Citation Count: 1
-
OPENTitle: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriersJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 8Start Page: 2546End Page: 2555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24543Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.24543?download=trueCitation Count: 21
- Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation states2023OPENTitle: Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation statesJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 34Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhad408Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10793575Citation Count: 28
-
OPENTitle: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2269End Page: 2281Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29611Citation Count: 12
- Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model2020OPENTitle: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-020-04994-7Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-020-04994-7Citation Count: 16
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease2023OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15
-
OPENTitle: Sex differences in LRRK2 G2019S and idiopathic Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 11Start Page: 801End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.489Best OA location URL: https://escholarship.org/content/qt61z1w0rn/qt61z1w0rn.pdfCitation Count: 35
-
OPENTitle: LRRK2 deficiency impacts ceramide metabolism in brainJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 478Issue #: 3Start Page: 1141End Page: 1146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082Best OA location URL: https://discovery.ucl.ac.uk/1508867/1/Plotegher.pdfCitation Count: 58
-
OPENTitle: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.17111Best OA location URL: https://doi.org/10.7554/elife.17111Citation Count: 55
- Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders2024OPENTitle: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disordersJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 27Issue #: 4Start Page: 101251End Page: 101251Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.gim.2024.101251Best OA location URL: https://doi.org/10.1016/j.gim.2024.101251Citation Count: 0
- Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer’s Disease2017OPENTitle: Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2017.00580Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2017.00580/pdfCitation Count: 49
-
OPENTitle: Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202013257Best OA location URL: https://doi.org/10.15252/emmm.202013257Citation Count: 128
-
OPENTitle: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 5Start Page: 2627End Page: 2634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23547Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23547Citation Count: 49
- Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI2021OPENTitle: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMIJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00241-3Best OA location URL: https://www.nature.com/articles/s41531-021-00241-3.pdfCitation Count: 43
- The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset2023OPENTitle: The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 59Issue #: 6Start Page: 1169End Page: 1176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16104Citation Count: 3
-
RESTRICTEDTitle: Parkinson's Disease Gene Screening in Familial Cases from Central and South AmericaJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 10Start Page: 1843End Page: 1855Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29931Best OA location URL: https://doi.org/10.1002/mds.29931Citation Count: 2
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 5
- Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives2018RESTRICTEDTitle: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected RelativesJournal Name: Brain TopographyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 6Start Page: 1029End Page: 1036Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8Citation Count: 27
-
OPENTitle: ARSA variants in α-synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 12Start Page: e70End Page: e70Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz340Best OA location URL: https://academic.oup.com/brain/article-pdf/142/12/e70/31499429/awz340.pdfCitation Count: 19
-
OPENTitle: Constructing de Novo H2O2 Signaling via Induced Protein ProximityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 6Start Page: 1404End Page: 1410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b00170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4849873Citation Count: 16
-
RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001Citation Count: 0
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction2018RESTRICTEDTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Citation Count: 33
-
OPENTitle: ScRNAbox: empowering single-cell RNA sequencing on high performance computing systemsJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 25Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-024-05935-yBest OA location URL: https://link.springer.com/content/pdf/10.1186/s12859-024-05935-y.pdfCitation Count: 2